The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours

Recruiting N/A Interventional Study
Schizophrenia Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
40 (estimated)
Sponsor
Kastamonu University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Schizophrenia is a chronic, recurrent and disabling illness that usually lasts a lifetime and causes serious problems in quality of life and functioning. Psychoeducation programmes added to drug treatment in the treatment of schizophrenia have been shown to increase the knowledge of patients and their relatives about the disease, coping skills, prevention of exacerbations and relapses of the disea…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Having been diagnosed with schizophrenia 2. TRSM registered and continuing 3. Acceptance to work and training Exclusion Criteria: 1. Have not been diagnosed with schizophrenia 2. If he/she does not agree to participate in the study 3. If not registered with TRSM
Contacts

Havva K KAÇAN, ASSOCIATE PROFESSOR DOCTOR

05057753893

hkacan@kastamonu.edu.tr

CONTACT

Şevval Y YEYİT, Research Assistant

0546 542 0536

syeyit@kastamonu.edu.tr

CONTACT